Physician profile
Mark A Ammons
NPI 1982600037
$2,811.43
in general payments reported to CMS, 2019-2025
13 companies · $607 in 2025
The $607 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $238 · 2021: $145 · 2022: $481 · 2023: $184 · 2024: $605 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,618.72 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien Xt Transcatheter Heart Valve (Thv), Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $285.09 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $279.57 | 2019 | |
| Abiomed | $148.50 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $129.07 | 2022 | |
| Shockwave Medical, INC | $117.51 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $68.32 | 2019 | |
| Dilon Technologies, INC. | $40.65 | 2023 | Hemoblast Bellows |
| Angiodynamics, INC. | $35.89 | 2020 | |
| W. L. Gore & Associates, INC. | $25.53 | 2024 | Gore Cardioform Septal Occluder |
| Cerus Corporation | $25.35 | 2023 | Intercept Blood System For Platelets |
| Janssen Pharmaceuticals, INC | $21.76 | 2024 | Xarelto |
| Artivion, INC. | $15.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ammons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.